These findings have revealed that the anti-inflammatory and neuroprotective mechanisms of dauricine might lead to the suppression of microglia activation via targeting the inhibition of STAT5-NF-κB in ischemic stroke. This evidence concerns the gene STAT5B and ischemic stroke.